Page last updated: 2024-11-01

nifedipine and Idiopathic Parkinson Disease

nifedipine has been researched along with Idiopathic Parkinson Disease in 3 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, XJ1
Xu, JX1
Hashimoto, T1
Yabe-Nishimura, C1
Nishino, N1
Noguchi-Kuno, SA1
Sugiyama, T1
Tanaka, C1

Other Studies

3 other studies available for nifedipine and Idiopathic Parkinson Disease

ArticleYear
Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Neuroscience letters, 2005, Mar-11, Volume: 376, Issue:2

    Topics: Apoptosis; Calcium; Calcium Channel Blockers; Caspases; Cell Cycle; Cell Line, Tumor; Chelating Agen

2005
Oxidative metabolite of dopamine, 3,4-dihydroxyphenylacetaldehyde, induces dopamine release from PC12 cells by a Ca2+-independent mechanism.
    Brain research, 2002, Mar-22, Volume: 931, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium; Calcium Channel Blockers; Dopamine; L-Lactate Dehy

2002
[3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
    Brain research, 1986, Jul-02, Volume: 377, Issue:1

    Topics: Aged; Binding Sites; Caudate Nucleus; Corpus Striatum; Female; Globus Pallidus; Humans; Male; Nifedi

1986